Search hospitals > Pennsylvania > Bethlehem
Saint Luke's University Hospital-Bethlehem Campus
Claim this profileBethlehem, Pennsylvania 18015
Global Leader in Cancer
Global Leader in Melanoma
Conducts research for Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Recurrence
209 reported clinical trials
19 medical researchers
Summary
Saint Luke's University Hospital-Bethlehem Campus is a medical facility located in Bethlehem, Pennsylvania. This center is recognized for care of Cancer, Melanoma, Breast Cancer, Adenocarcinoma, Recurrence and other specialties. Saint Luke's University Hospital-Bethlehem Campus is involved with conducting 209 clinical trials across 318 conditions. There are 19 research doctors associated with this hospital, such as Neil D. Belman, Melissa A. Wilson, Darius Desai, and Gary Lu.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Melanoma
Global LeaderStage IV
Stage III
BRAF positive
Top PIs
Neil D. BelmanSaint Luke's University Hospital-Bethlehem Campus10 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
4 reported clinical trials
8 drugs studied
Melissa A. WilsonSt. Lukes University Health Network8 years of reported clinical research
Studies Melanoma
Studies Skin Cancer
5 reported clinical trials
9 drugs studied
Darius DesaiSt. Luke's University Health Network - Allentown Cancer Center3 years of reported clinical research
Studies Pancreatic Cancer
Studies Skin Cancer
4 reported clinical trials
11 drugs studied
Gary LuSt. Lukes University Health Network5 years of reported clinical research
Studies Melanoma
Studies Cancer
4 reported clinical trials
11 drugs studied
Clinical Trials running at Saint Luke's University Hospital-Bethlehem Campus
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Prostate Cancer
Ovarian Cancer
Fallopian Tube Cancer
Tumors
Skin Cancer
Peritoneal Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Luke's University Hospital-Bethlehem Campus?
Saint Luke's University Hospital-Bethlehem Campus is a medical facility located in Bethlehem, Pennsylvania. This center is recognized for care of Cancer, Melanoma, Breast Cancer, Adenocarcinoma, Recurrence and other specialties. Saint Luke's University Hospital-Bethlehem Campus is involved with conducting 209 clinical trials across 318 conditions. There are 19 research doctors associated with this hospital, such as Neil D. Belman, Melissa A. Wilson, Darius Desai, and Gary Lu.